Article

What to do when the rhexis won’t tear

Metabolic insult from silicone oil exposure can cause lens epithelial cells to undergo fibrous metaplasia, making the lens capsule resistant to tearing. Instead of persisting in trying to initiate a tear, surgeons should use an instrument to cut through the fibrotic material. This non-standard approach for opening the capsule recognizes potential for capsular fibrosis in eyes filled with silicone oil.

Take-Home: Metabolic insult from silicone oil exposure can cause lens epithelial cells to undergo fibrous metaplasia, making the lens capsule resistant to tearing. Instead of persisting in trying to initiate a tear, surgeons should use an instrument to cut through the fibrotic material. This non-standard approach for opening the capsule recognizes potential for capsular fibrosis in eyes filled with silicone oil. 

Reviewed by Michael A. Mahr, MD

Rochester, MN-Chronic exposure to silicone oil can result in fibrous pseudometaplasia of lens epithelial cells that can make it impossible to initiate the capsulorhexis tear during cataract surgery.

Related: Tips for successful surgery with secondary IOLs

Surgeons who encounter this situation should abandon their standard capsulorhexis technique and create the anterior capsule opening, instead using an instrument for cutting through the toughened tissue, said Michael A. Mahr, MD.

“Surgeons should not hesitate to cut the capsule due to concern about causing a radial tear because the good news is: a capsule that won’t intentionally tear because it is fibrotic is also less likely to unintentionally tear,” said Dr. Mahr, assistant professor of ophthalmology, Mayo Clinic, Rochester, MN. “On the other hand, surgeons should recognize that continued effort to tear the capsule is risky as the stress can lead to zonular damage or some other problem.”

Recent: Integrating computer-assisted toric IOL implantation

Dr. Mahr spoke from personal experience with a patient who was referred for surgery for a white cataract. The patient had undergone vitreoretinal surgery eight years earlier for a giant retinal tear with pars plana vitrectomy, endolaser, scleral buckle, and placement of silicone oil that was never removed.

Micro-scissors

 

Micro-scissors used

When the flap would not tear, Dr. Mahr instead used micro-scissors to cut and amputate a series of flaps in the capsule to create the capsulotomy. Because the posterior capsule was also white and opacified, he initiated an opening by puncturing the capsule with a bent needle and completed the posterior capsulotomy using a vitrector.

Recent: Eye health awareness campaign aims to open public's eyes

“Opening the posterior capsule was necessary to allow visual rehabilitation in this patient and would also be needed for silicone oil removal,” Dr. Mahr explained. “I was unsure about how effective Nd:YAG laser capsulotomy would be in this situation, and so we chose to open the posterior capsule during the cataract procedure instead.”

Fibrous transformation of lens epithelial cells in phakic eyes filled with silicone oil was described in a paper published by Spraul et al. [Graefes Arch Clin Exp Ophthalmol. 2002;240(10):829-834.] The investigators reported findings from histological evaluation that showed spindle-shaped cells resembling fibroblast that were surround by basement membrane and associated with collagen fibrils.

Related: Upgrades to intraop aberrometer enhance surgical feedback

“The basement membrane is a feature of epithelial cells and the collagen fibrils are a feature of fibroblasts,” Dr. Mahr said. “When we are trying to make the rhexis in an eye with this fibrous pseudometaplasia, we are trying to tear collagen connective tissue that has become ligament- or tendon-like rather than basement membrane.”

Capitalizing on the change

 

Capitalizing on the change

Dr. Mahr proposed that lens epithelial cell fibrous metaplasia might also occur in other scenarios, such as after unintentional posterior capsule penetration during posterior vitrectomy or intravitreal injections. Considering that possibility, there might be a safety advantage for delaying cataract surgery in those situations.

Related: Transzonular intravitreal injection eases treatment burden after cataract surgery

“With sufficient time after the iatrogenic insult, perhaps over a period of months or longer, and given an adequate capsular scaffolding, the fibrous metaplastic phenomenon may allow for the formation of a focal, more localized pseudocapsular plaque,” Dr. Mahr explained. “The plaque can be thought of as a capsular bandage that would potentially provide mechanical integrity to a compromised posterior capsule that would otherwise be at high risk for radializing.”

More: Intracameral phenylephrine/ketorolac superior to intracameral epinephrine

 

Michael A. Mahr, MD

e. mahr.michael@mayo.edu

This article is based on a presentation given by Dr. Mahr at the 2016 ASCRS Annual Meeting. He has no relevant financial interests to disclose.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.